Initial Investigations for Fever and Lymphadenopathy
The initial investigations for a patient presenting with fever and lymphadenopathy should include complete blood count with differential, blood cultures, comprehensive metabolic panel, chest X-ray, and appropriate serological testing based on epidemiological risk factors. 1
Basic Laboratory Investigations
First-line Tests
- Complete blood count (CBC) with differential
- Look for: lymphopenia (viral infections, HIV, typhoid), eosinophilia (parasitic infections), thrombocytopenia (malaria, dengue, acute HIV) 1
- Blood cultures (two sets)
- Essential to identify bacteremia, particularly important if typhoid is suspected (sensitivity up to 80%) 1
- Comprehensive metabolic panel
- Liver function tests to assess for hepatitis or liver involvement 1
- Renal function tests to evaluate kidney function
- Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)
- Elevated in inflammatory and infectious conditions 1
- Lactate dehydrogenase (LDH)
- May be elevated in malignancies, particularly lymphomas 1
Serological Testing
- HIV testing
- EBV serology (monospot test and/or EBV-specific antibodies)
- Particularly important in patients with prominent pharyngitis and posterior cervical lymphadenopathy 2
- CMV serology
- Consider in mononucleosis-like syndrome with negative EBV testing 2
- Additional serological tests based on epidemiological risk:
Imaging Studies
- Chest X-ray
- Indicated for all patients with fever and lymphadenopathy to evaluate for hilar/mediastinal lymphadenopathy, pulmonary infiltrates, or masses 1
- Ultrasound of affected lymph node regions
- Helpful to characterize lymphadenopathy and guide potential biopsy 1
- CT scan of neck, chest, abdomen, and pelvis with contrast
- Consider when lymphoma or disseminated infection is suspected 1
- PET/CT scan
- Consider when malignancy is suspected, particularly lymphoma 1
Specialized Testing
Lymph Node Evaluation
- Excisional lymph node biopsy
Microbiological Testing
- Tuberculosis testing
- Tuberculin skin test or interferon-gamma release assay
- Consider in patients with risk factors or from endemic areas 1
- Malaria testing
- Blood films and rapid diagnostic tests for patients with travel to endemic areas 1
Algorithm Based on Clinical Presentation
For Acute Presentation (<2 weeks)
- CBC, blood cultures, basic metabolics, LFTs, ESR/CRP
- Chest X-ray
- Monospot test/EBV serology
- HIV testing
- Consider empiric treatment for bacterial infection if clinically indicated
For Subacute/Chronic Presentation (>2 weeks)
- All tests from acute presentation
- CT scan of affected regions
- Additional serologies based on exposure history
- Consider lymph node biopsy if diagnosis remains unclear after initial testing
Special Considerations
Travel History
- For returning travelers, include specific testing based on geographic exposure:
- Malaria testing for travelers to endemic areas
- Dengue, chikungunya for appropriate travel history
- Parasitic infections (filariasis, schistosomiasis) based on exposure 1
Immunocompromised Patients
- More aggressive initial workup including:
- Blood cultures from all central venous catheter lumens 1
- Consider fungal cultures and serology
- Lower threshold for CT imaging and biopsy
Common Pitfalls to Avoid
- Premature diagnosis of viral syndrome - Always consider serious bacterial infections and malignancies
- Failure to obtain adequate blood cultures - Ensure proper volume and timing
- Missing travel and exposure history - Critical for identifying tropical and zoonotic infections
- Delaying lymph node biopsy - Consider early in cases of persistent unexplained lymphadenopathy
- Overlooking HIV - Test all patients with unexplained fever and lymphadenopathy
By following this systematic approach to investigating fever and lymphadenopathy, clinicians can efficiently identify the underlying cause and initiate appropriate management to improve patient outcomes.